{"title":"Incremental value of physiological indices to predict high-risk plaques detected by NIRS-IVUS.","authors":"Kazuyoshi Kakehi, Masafumi Ueno, Nobuhiro Yamada, Kyohei Onishi, Keishiro Sugimoto, Yohei Funauchi, Takayuki Kawamura, Kosuke Fujita, Hiroki Matsuzoe, Koichiro Matsumura, Gaku Nakazawa","doi":"10.1007/s12928-025-01116-7","DOIUrl":null,"url":null,"abstract":"<p><p>Identification of vulnerable plaques is important for reducing future cardiovascular events. This study aimed to investigate optimal modalities other than intravascular imaging in evaluating vulnerable plaques. We prospectively evaluated 105 non-culprit coronary lesions by CCTA imaging and near-infrared spectroscopy-intravascular ultrasound in 32 patients with acute coronary syndrome. Angiographically-derived ΔQFR and ΔFFR<sub>CT</sub> were measured as the difference in QFR and FFR<sub>CT</sub> across the stenosis. A receiver operating characteristic curve analysis was performed to determine the optimal cutoff values of angiographically- and CCTA-derived plaque features for a maxLCBI<sub>4mm</sub> ≥ 400. The best cutoff values for ΔQFR and ΔFFR<sub>CT</sub> to predict a maxLCBI<sub>4mm</sub> ≥ 400 were 0.05 and 0.06, respectively. ΔQFR and ΔFFR<sub>CT</sub> values and percent diameter stenosis on QCA or CCTA were associated with a maxLCBI<sub>4mm</sub> ≥ 400 (both P < 0.05). The combination of ΔFFR<sub>CT</sub> ≥ 0.06 and plaque density predicted a maxLCBI<sub>4mm</sub> ≥ 400 with 89.4% sensitivity and 84.5% specificity (area under the curve, 0.90; P < 0.0001). There was no significant difference in area under the curve values between ΔQFR and plaque density + ΔFFR<sub>CT</sub> ≥ 0.06 (0.92 vs. 0.90, P = 0.50). In the diagnosis of vulnerable plaques in acute coronary syndrome, the combination of ΔFFR<sub>CT</sub> and plaque density shows a diagnostic capability similar to that of ΔQFR in non-culprit lesions.</p>","PeriodicalId":9439,"journal":{"name":"Cardiovascular Intervention and Therapeutics","volume":" ","pages":""},"PeriodicalIF":3.1000,"publicationDate":"2025-03-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cardiovascular Intervention and Therapeutics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/s12928-025-01116-7","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0
Abstract
Identification of vulnerable plaques is important for reducing future cardiovascular events. This study aimed to investigate optimal modalities other than intravascular imaging in evaluating vulnerable plaques. We prospectively evaluated 105 non-culprit coronary lesions by CCTA imaging and near-infrared spectroscopy-intravascular ultrasound in 32 patients with acute coronary syndrome. Angiographically-derived ΔQFR and ΔFFRCT were measured as the difference in QFR and FFRCT across the stenosis. A receiver operating characteristic curve analysis was performed to determine the optimal cutoff values of angiographically- and CCTA-derived plaque features for a maxLCBI4mm ≥ 400. The best cutoff values for ΔQFR and ΔFFRCT to predict a maxLCBI4mm ≥ 400 were 0.05 and 0.06, respectively. ΔQFR and ΔFFRCT values and percent diameter stenosis on QCA or CCTA were associated with a maxLCBI4mm ≥ 400 (both P < 0.05). The combination of ΔFFRCT ≥ 0.06 and plaque density predicted a maxLCBI4mm ≥ 400 with 89.4% sensitivity and 84.5% specificity (area under the curve, 0.90; P < 0.0001). There was no significant difference in area under the curve values between ΔQFR and plaque density + ΔFFRCT ≥ 0.06 (0.92 vs. 0.90, P = 0.50). In the diagnosis of vulnerable plaques in acute coronary syndrome, the combination of ΔFFRCT and plaque density shows a diagnostic capability similar to that of ΔQFR in non-culprit lesions.
期刊介绍:
Cardiovascular Intervention and Therapeutics (CVIT) is an international journal covering the field of cardiovascular disease and includes cardiac (coronary and noncoronary) and peripheral interventions and therapeutics. Articles are subject to peer review and complete editorial evaluation prior to any decision regarding acceptability. CVIT is an official journal of The Japanese Association of Cardiovascular Intervention and Therapeutics.